The importance of R327 in the burns unit, a coming rationale :
30% of adults after a greater than 30 % full thickness burn FTB ( there are 3 layers of skin that are damaged) become immunosuppressed.
If a child has a greater than 20% FTB their chances of infection are approximately 22%.
In 2016 there was 40,000 in admissions from burns in the USA.
The problem is basically after the skin integrity is lost infection has an easy central pathway, therefore most people die from secondary infection than the trauma of burns itself.
42 to 65% of these deaths are also due to current anti biotics resistance , it causes a viscous cycle. R 327 has no resistance.
Results from R327 are imminent, this will be a game changer for RCE. Pharmaceuticals use Companies like RCE to develop their niche drugs ( happening since 2007 approximately)
RCE type Companies use the revenue stream to then pay for more trials on different diseases. It goes around in a natural preselection of good Companies get rewarded.
RCE turn is about to happen. Hang on enjoy the feeling of supporting the Company and now the Company supporting you. Well done for the long termers of this Stock.
RCE Price at posting:
99.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)